The global medical industry experienced a 33% rise in company filings mentions of future of work in Q2 2023 compared with the previous quarter, with the highest share accounted for by Becton Dickinson and Co with 38% year-on-year increase, according to GlobalData’s analysis of over 248 medical company filings. GlobalData’s Future of Work – Thematic Research report explains how the theme future of work is impacting the workforce across different sectors, it presents key technology, macroeconomic and regulatory trends, market size and growth forecasts for technologies that will play a key role in the theme. Buy the report here.
Notably, future of work was one of the most frequently referenced themes in Q2 2023, ranking highest in terms of mentions, ahead of connectivity and digitalization, according to GlobalData.
Of the top leading companies in the medical industry, Becton Dickinson and Co had the greatest increase in references for future of work in Q2 2023, compared with the previous quarter. GlobalData identified 11 future of work-related sentences in the company's filings - 1% of all sentences - and an increase of 38% in Q2 2023 compared with Q2 2022. Bio-Techne’s mentions of future of work rose by 350% to 9 and DexCom’s by 50% to 9 and Baxter International’s by 600% to 7 and Abbott Laboratories’s by 500% to 6.
GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for future of work in Q2 2023 was 98.
For further understanding of GlobalData's Future of Work – Thematic Research buy the report here.